Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PHILIP D LEMING

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1679569842
CMS profile
303083
Location
CINCINNATI, OH

General Payments · PY2018–2024

$7,517.92

  • Reported across 133 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$458.02

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $458.02 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $503.31 28
PY2019 $768.70 66
PY2020 $2,541.99 3
PY2021 $2,676.16 4
PY2022 $353.20 9
PY2023 $216.54 6
PY2024 $458.02 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $30.13 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105610101 CMS
AstraZeneca Pharmaceuticals LP $28.68 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105549713 CMS
AstraZeneca Pharmaceuticals LP $24.55 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105618923 CMS
Daiichi Sankyo Inc. $20.00 02/13/2024 Food and Beverage Undisputed 01/23/2026 1089448122 CMS
Daiichi Sankyo Inc. $21.41 08/21/2024 Food and Beverage Undisputed 01/23/2026 1089448124 CMS
E.R. Squibb & Sons, L.L.C. $20.24 05/09/2024 Food and Beverage Undisputed 01/23/2026 1101245564 CMS
Gilead Sciences, Inc. $25.05 05/09/2024 Food and Beverage Undisputed 01/23/2026 1133799424 CMS
Gilead Sciences, Inc. $21.65 11/11/2024 Food and Beverage Undisputed 01/23/2026 1133799426 CMS
Immunocore Limited $16.98 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103097033 CMS
Janssen Biotech, Inc. $15.09 12/10/2024 Food and Beverage Undisputed 01/23/2026 1078490775 CMS
Merck Sharp & Dohme LLC $18.56 03/20/2024 Food and Beverage Undisputed 01/23/2026 1141895563 CMS
Merck Sharp & Dohme LLC $34.69 09/18/2024 Food and Beverage Undisputed 01/23/2026 1141778035 CMS
PROGENICS PHARMACEUTICALS, INC. $16.22 07/11/2024 Food and Beverage Undisputed 01/23/2026 1128507600 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.54 07/24/2024 Food and Beverage Undisputed 01/23/2026 1144961636 CMS
Tempus AI, Inc $98.42 04/23/2024 Food and Beverage Undisputed 01/23/2026 1150168448 CMS
Tempus AI, Inc $28.62 12/11/2024 Food and Beverage Undisputed 01/23/2026 1150168450 CMS
Tolmar, Inc. $17.19 12/03/2024 Food and Beverage Undisputed 01/23/2026 1138709243 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.